Cabaletta Bio Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.00

+0.11 (+5.82%)

As of Oct 4, 10:45 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 81%

Hold 3 19%

Sell 0 0%

Price Target

Analyst Price Target +1,889.5% upside

Low Target $29.42

Average Target $39.79

High Target $58.63

Current Price $2.00

Current
$2.00

Target
$39.79

$29.42 $39.79 avg $58.63

Scenario Analysis

Bear Case

$29.42

1,371.0%

Low target

Base Case

$39.79

+1,889.5%

Avg target

Bull Case

$58.63

+2,831.5%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$4.23

-52.7% from high

52-Week Low

$1.86

+7.5% from low

Target vs 52W High

$39.79

+840.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-52.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+150.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-21.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.8%